Disappointing result.
IIQ will need to tweak a few things to see if the ovarian cancer test is much better than what is already available on the market, before putting more money into clinical validation.
As a precaution, I would write off the potential value of ovarian cancer test.
Disappointing result.IIQ will need to tweak a few things to see...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.99M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2115 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 18000 | 1 |
View Market Depth
| Last trade - 16.12pm 07/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |
Day chart unavailable